Research ArticleRESEARCH ARTICLE

In Vitro Hemolysis and Buffer Capacity Studies With the Novel Marine Anticancer Agent Kahalalide F and Its Reconstitution Vehicle Cremophor EL/Ethanol

Bastiaan Nuijen, Marjan Bouma, Consuelo Manada, José M. Jimeno, Aune Bult and Jos H. Beijnen
PDA Journal of Pharmaceutical Science and Technology July 2001, 55 (4) 223-229;

Article Information

vol. 55 no. 4 223-229
PubMed 
11505554
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online July 1, 2001.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Bastiaan Nuijen1,*,
  2. Marjan Bouma1,
  3. Consuelo Manada2,
  4. José M. Jimeno2,
  5. Aune Bult3 and
  6. Jos H. Beijnen1,3
  1. 1Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, The Netherlands;
  2. 2Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands;
  3. 3Faculty of Pharmacy, Utrecht University, Utrecht, The Netherlands
  1. * Author to whom correspondence should be addressed:
    Slotervaart Hospital/The Netherlands Cancer Institute, Dept. of Pharmacy & Pharmacology, Louwesweg 6, 1066EC Amsterdam, The Netherlands
    , Tel: (31) 20 512 4482. E-mail: apbnu{at}slz.nl

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
In Vitro Hemolysis and Buffer Capacity Studies With the Novel Marine Anticancer Agent Kahalalide F and Its Reconstitution Vehicle Cremophor EL/Ethanol
Bastiaan Nuijen, Marjan Bouma, Consuelo Manada, José M. Jimeno, Aune Bult, Jos H. Beijnen
PDA Journal of Pharmaceutical Science and Technology Jul 2001, 55 (4) 223-229;
Twitter logo Facebook logo Mendeley logo

Jump to section